{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T05:23:44Z","timestamp":1787203424471,"version":"build-2736575974"},"reference-count":43,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIH","award":["NIH R35 HL135736"],"award-info":[{"award-number":["NIH R35 HL135736"]}]},{"name":"NIH","award":["R35 HL171080"],"award-info":[{"award-number":["R35 HL171080"]}]},{"name":"NIH","award":["P30 CA138313"],"award-info":[{"award-number":["P30 CA138313"]}]},{"name":"NIH","award":["NIH 1S10OD026913"],"award-info":[{"award-number":["NIH 1S10OD026913"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Charcot-Marie-Tooth (CMT) disease type 2A is a rare heritable disorder caused by pathogenic variants of mitofusin (MFN) 2 that suppress mitochondrial fusion and motility in peripheral nerves, culminating in denervation myoatrophy. The rarity of this condition and the limited choice of animal models preclude pre-clinical evaluation of many tests that could be translated to human trials. Here, we introduced the CMT2A pathogenic variant MFN2 T105M into the rat genome for phenotype characterization and evaluation of disease response to a third-generation mitofusin activator, 8015-P2. CMT2A rats exhibited peripheral motor and sensory neuron dysfunction. Functional, histological, neuroelectrophysiological and magnetic resonance imaging testing readily distinguished between wild-type (WT) and mutant rats via axonopathy and myoatrophy. Compound 8015-P2 reversed CMT2A-linked neuromuscular degeneration in a dose- and time-dependent manner; at 10 mg\/kg\/d, normalization occurred at 4 weeks. The minimal effective 8015-P2 dose was 2 mg\/kg\/day. Rapidity of phenotype reversal and primary muscle abnormalities are consistent with extra-neuronal effects of the causal MFN2 DNA variant. These data demonstrate unprecedented utility of the Mfn2 T105M rat as a model of CMT2A, expand the menu of clinically applicable tests that may have use in future human trials, and establish a strong foundation for exploration of extra-neuronal consequences of pathogenic mitofusin variants in non-mouse models.<\/jats:p>","DOI":"10.3390\/ijms27167376","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T10:22:52Z","timestamp":1787048572000},"page":"7376","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neuromuscular Dysfunction and Charcot-Marie-Tooth Disease Reversal in Mfn2 T105M Knock-In Rats"],"prefix":"10.3390","volume":"27","author":[{"given":"Jochen","family":"Weigele","sequence":"first","affiliation":[{"name":"Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, 171 Ashley Ave, Charleston, SC 29425, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5487-1800","authenticated-orcid":false,"given":"Antonietta","family":"Franco","sequence":"additional","affiliation":[{"name":"Center for Pharmacogenomics, Department of Internal Medicine, Washington University in St. Louis, Saint Louis, MO 63110, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"Gerald W.","family":"Dorn","sequence":"additional","affiliation":[{"name":"Department of Regenerative Medicine and Cell Biology, Medical University of South Carolina, 171 Ashley Ave, Charleston, SC 29425, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1007\/s13311-021-01099-2","article-title":"Axonal Charcot-Marie-Tooth Disease: From Common Pathogenic Mechanisms to Emerging Treatment Opportunities","volume":"18","author":"McCray","year":"2021","journal-title":"Neurotherapeutics"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/B978-0-323-98818-6.00009-1","article-title":"Hereditary neuropathy","volume":"195","author":"Pisciotta","year":"2023","journal-title":"Handb. Clin. Neurol."},{"key":"ref_3","first-page":"97","article-title":"Sur une forme particuli\u00e8re d\u2019atrophie musculaire progressive souvent familiale d\u00e9butant par les pieds et les jambes et atteignant plus tard les mains","volume":"6","author":"Marie","year":"1886","journal-title":"Rev. M\u00e9d. Paris"},{"key":"ref_4","unstructured":"Tooth, H. (1886). The Peroneal Type of Progressive Muscular Atrophy. [MD Dissertation, University of Cambridge]."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/archneur.1968.00470360025002","article-title":"Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. I. Neurologic, genetic, and electrophysiologic findings in hereditary polyneuropathies","volume":"18","author":"Dyck","year":"1968","journal-title":"Arch. Neurol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1001\/archneur.1968.00470360041003","article-title":"Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. II. Neurologic, genetic, and electrophysiologic findings in various neuronal degenerations","volume":"18","author":"Dyck","year":"1968","journal-title":"Arch. Neurol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0092-8674(91)90613-4","article-title":"DNA duplication associated with Charcot-Marie-Tooth disease type 1A","volume":"66","author":"Lupski","year":"1991","journal-title":"Cell"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/brain\/103.2.259","article-title":"The clinical features of hereditary motor and sensory neuropathy types I and II","volume":"103","author":"Harding","year":"1980","journal-title":"Brain"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1529-8027.2011.00324.x","article-title":"Charcot-Marie-Tooth disease","volume":"16","author":"Reilly","year":"2011","journal-title":"J. Peripher. Nerv. Syst."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/ng1341","article-title":"Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A","volume":"36","author":"Zuchner","year":"2004","journal-title":"Nat. Genet."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1212\/WNL.0b013e31821a441e","article-title":"MFN2 mutations cause severe phenotypes in most patients with CMT2A","volume":"76","author":"Feely","year":"2011","journal-title":"Neurology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"113281","DOI":"10.1016\/j.expneurol.2020.113281","article-title":"HDAC6 inhibition promotes alpha-tubulin acetylation and ameliorates CMT2A peripheral neuropathy in mice","volume":"328","author":"Picci","year":"2020","journal-title":"Exp. Neurol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e61119","DOI":"10.7554\/eLife.61119","article-title":"Burst mitofusin activation reverses neuromuscular dysfunction in murine CMT2A","volume":"9","author":"Franco","year":"2020","journal-title":"eLife"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1124\/jpet.122.001332","article-title":"Mitochondrial Dysfunction and Pharmacodynamics of Mitofusin Activation in Murine Charcot-Marie-Tooth Disease Type 2A","volume":"383","author":"Franco","year":"2022","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1124\/jpet.124.002258","article-title":"Sensory-Motor Neuropathy in Mfn2 T105M Knock-in Mice and Its Reversal by a Novel Piperine-Derived Mitofusin Activator","volume":"391","author":"Weigele","year":"2024","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1093\/brain\/awq082","article-title":"Expression of mitofusin 2R94Q in a transgenic mouse leads to Charcot-Marie-Tooth neuropathy type 2A","volume":"133","author":"Cartoni","year":"2010","journal-title":"Brain"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1172\/JCI124194","article-title":"Restoring mitofusin balance prevents axonal degeneration in a Charcot-Marie-Tooth type 2A model","volume":"129","author":"Zhou","year":"2019","journal-title":"J. Clin. Investig."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/hmg\/ddg075","article-title":"Transgenic rat model of Huntington\u2019s disease","volume":"12","author":"Schmitt","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1093\/brain\/awaa323","article-title":"Natural history of Charcot-Marie-Tooth disease type 2A: A large international multicentre study","volume":"143","author":"Pipis","year":"2020","journal-title":"Brain"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e84235","DOI":"10.7554\/eLife.84235","article-title":"A human mitofusin 2 mutation can cause mitophagic cardiomyopathy","volume":"12","author":"Franco","year":"2023","journal-title":"eLife"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.neuroimage.2006.01.015","article-title":"User-guided 3D active contour segmentation of anatomical structures: Significantly improved efficiency and reliability","volume":"31","author":"Yushkevich","year":"2006","journal-title":"Neuroimage"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.mambio.2016.12.002","article-title":"Sexual-size dimporphism in two synanthropic rat species: Comparison and eco-evolutionary perspectives","volume":"83","author":"Mori","year":"2016","journal-title":"Mamm. Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1242\/dmm.026120","article-title":"Rodent models in neuroscience research: Is it a rat race?","volume":"9","author":"Ellenbroek","year":"2016","journal-title":"Dis. Models Mech."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0960-8966(98)00018-2","article-title":"Charcot-Marie-Tooth disease\u2013muscle biopsy findings in relation to neurophysiology","volume":"8","author":"Ericson","year":"1998","journal-title":"Neuromuscul. Disord."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"112434","DOI":"10.1016\/j.celrep.2023.112434","article-title":"Mitochondrial dynamics define muscle fiber type by modulating cellular metabolic pathways","volume":"42","author":"Yasuda","year":"2023","journal-title":"Cell Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1523\/JNEUROSCI.4798-06.2007","article-title":"Altered axonal mitochondrial transport in the pathogenesis of Charcot-Marie-Tooth disease from mitofusin 2 mutations","volume":"27","author":"Baloh","year":"2007","journal-title":"J. Neurosci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nrd.2018.76","article-title":"Neurodegenerative disorders: Rescuing mitochondrial motility","volume":"17","author":"Crunkhorn","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.hcl.2013.04.002","article-title":"Nerve physiology: Mechanisms of injury and recovery","volume":"29","author":"Menorca","year":"2013","journal-title":"Hand Clin."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Dubuisson, N., Versele, R., Planchon, C., Selvais, C.M., Noel, L., Abou-Samra, M., and Davis-L\u00f3pez de Carrizosa, M.A. (2022). Histological Methods to Assess Skeletal Muscle Degeneration and Regeneration in Duchenne Muscular Dystrophy. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232416080"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Dang, X., Walton, E.K., Zablocka, B., Baloh, R.H., Shy, M.E., and Dorn, G.W. (2022). Mitochondrial Phenotypes in Genetically Diverse Neurodegenerative Diseases and Their Response to Mitofusin Activation. Cells, 11.","DOI":"10.3390\/cells11061053"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e161566","DOI":"10.1172\/JCI161566","article-title":"A SARM1-mitochondrial feedback loop drives neuropathogenesis in a Charcot-Marie-Tooth disease type 2A rat model","volume":"132","author":"Strickland","year":"2022","journal-title":"J. Clin. Investig."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3390\/chemistry4030047","article-title":"Piperine Derivatives Enhance Fusion and Axonal Transport of Mitochondria by Activating Mitofusins","volume":"4","author":"Zhang","year":"2022","journal-title":"Chemistry"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"7033","DOI":"10.1021\/acs.jmedchem.0c00366","article-title":"Discovery of 6-Phenylhexanamide Derivatives as Potent Stereoselective Mitofusin Activators for the Treatment of Mitochondrial Diseases","volume":"63","author":"Dang","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"12506","DOI":"10.1021\/acs.jmedchem.1c00163","article-title":"Pharmacophore-Based Design of Phenyl-[hydroxycyclohexyl] Cycloalkyl-Carboxamide Mitofusin Activators with Improved Neuronal Activity","volume":"64","author":"Dang","year":"2021","journal-title":"J. Med. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1126\/science.aao1785","article-title":"MFN2 agonists reverse mitochondrial defects in preclinical models of Charcot-Marie-Tooth disease type 2A","volume":"360","author":"Rocha","year":"2018","journal-title":"Science"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/nature20156","article-title":"Correcting mitochondrial fusion by manipulating mitofusin conformations","volume":"540","author":"Franco","year":"2016","journal-title":"Nature"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Li, J., Dang, X., Franco, A., and Dorn, G.W. (2022). Reciprocal Regulation of Mitofusin 2-Mediated Mitophagy and Mitochondrial Fusion by Different PINK1 Phosphorylation Events. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.868465"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1093\/hmg\/ddac287","article-title":"Activating mitofusins interrupts mitochondrial degeneration and delays disease progression in SOD1 mutant amyotrophic lateral sclerosis","volume":"32","author":"Dang","year":"2023","journal-title":"Hum. Mol. Genet."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Dorn, G.W. (2023). Reversing Dysdynamism to Interrupt Mitochondrial Degeneration in Amyotrophic Lateral Sclerosis. Cells, 12.","DOI":"10.3390\/cells12081188"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1146\/annurev-genet-110410-132529","article-title":"Fusion and fission: Interlinked processes critical for mitochondrial health","volume":"46","author":"Chan","year":"2012","journal-title":"Annu. Rev. Genet."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e210120","DOI":"10.1212\/WNL.0000000000210120","article-title":"Clinical Outcome Assessments and Biomarkers in Charcot-Marie-Tooth Disease","volume":"103","author":"McCray","year":"2024","journal-title":"Neurology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/mus.27041","article-title":"A well-tolerated core needle muscle biopsy process suitable for children and adults","volume":"62","author":"Barthelemy","year":"2020","journal-title":"Muscle Nerve"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1152\/physrev.00019.2003","article-title":"Cellular and molecular regulation of muscle regeneration","volume":"84","author":"Charge","year":"2004","journal-title":"Physiol. Rev."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/16\/7376\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T04:30:08Z","timestamp":1787200208000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/16\/7376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":43,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["ijms27167376"],"URL":"https:\/\/doi.org\/10.3390\/ijms27167376","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,18]]}}}